Form 8-K - Current report:
SEC Accession No. 0001420720-22-000006
Filing Date
2022-05-02
Accepted
2022-05-02 16:01:29
Documents
13
Period of Report
2022-04-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20220428x8k.htm   iXBRL 8-K 34635
2 EX-10.1 ibio-20220428xex10d1.htm EX-10.1 102575
  Complete submission text file 0001420720-22-000006.txt   268952

Data Files

Seq Description Document Type Size
3 EX-101.SCH ibio-20220428.xsd EX-101.SCH 2765
4 EX-101.LAB ibio-20220428_lab.xml EX-101.LAB 13522
5 EX-101.PRE ibio-20220428_pre.xml EX-101.PRE 10118
7 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20220428x8k_htm.xml XML 4575
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 22881803
SIC: 2834 Pharmaceutical Preparations